|
|
 |
|
Viewing report
|
|
|
|
US Glucose Monitoring Market Analysis
RNCOS E-Services Private Limited, Nov 2011, Pages: 55
The US has a dominant share in the global diabetes market with 90-95% of the diabetic patients in the country suffering from type-II diabetes. Factors like, high prevalence of diabetes, rising aging population and the increasing incidence of diabetes associated with Western diets have contributed to such stupendous escalation of the diabetes population in the US, further affecting the market for glucose monitoring devices in the country.
According to the report, “US Glucose Monitoring Market Analysis”, the glucose monitoring market in the country is expected to grow at a CAGR of approximately 8% during 2010-2015. Factors, such as steady increase in the number of people diagnosed with diabetes, along with intensive management and treatment processes/procedures are expected to sustain a high market growth rate in the glucose monitoring market. Additionally, from product categories, including blood glucose test strips, monitors, and lancet/lancet devices are expected to register significant growth rates.
Our industry research disclosed that the US market for glucose monitoring is highly competitive. Leading players in the US offering blood glucose monitoring and testing systems include Abbott Diabetes Care, Bayer Healthcare, LifeScan, Medtronic, and Roche Diagnostics. Further, Glucometer DEX, AccuChek, One Touch, and SureStep are some leading brands of the global market.
According to “US Glucose Monitoring Market Analysis”, the US glucose monitoring market was analyzed, by segmenting it into glucose strips, blood glucose meters, continuous glucose meter, and lancets. Each of these sectors have been thoroughly studied and analyzed in the report. Also, the report gives an overview of the patient profile and cost implications of diabetes in the country, which will help customers in determining the future demand scenario.
|
|
|
|
